Doximity rolls out AI tools at major medical systems
NewYork-Presbyterian, Columbia University and Weill Cornell Medicine began deploying Doximity's Doximity Ask and Doximity Scribe artificial intelligence tools within their Epic electronic health record systems. This integration expands clinician capabilities for decision-making and medical documentation across these large academic institutions.
Key points
- Doximity announced the deployment of its specialized AI tools at three major medical systems.
- This new AI rollout builds on Doximity's ongoing collaboration with NewYork-Presbyterian, dating back to 2021.
- Director Timothy S. Cabral converted derivative securities and sold 10,721 shares on November 5, 2026, under a Rule 10b5-1 trading plan—a preset selling schedule executives set up in advance—for $375,235.
Integrating clinical AI into medical systems
Doximity announced the deployment of its specialized AI tools at three major medical systems. Doximity Ask provides clinical decision support based on peer-reviewed medical literature, clinical guidelines and physician peer reviews, while Scribe assists with documentation automation, including dictation and drafting notes during patient visits.
Expanding collaboration with medical institutions
This new AI rollout builds on Doximity's ongoing collaboration with NewYork-Presbyterian, dating back to 2021. Previous interaction with the facility focused on using the Dialer tool for audio and video consultations.
Company insider transactions
Director Timothy S. Cabral converted derivative securities and sold 10,721 shares on November 5, 2026, under a Rule 10b5-1 trading plan—a preset selling schedule executives set up in advance—for $375,235.
Additionally, on November 16, 2026, officer Siddharth Sitaram filed a Form 144 notice of a proposed sale for 2,523 shares obtained through a stock option exercise. The plan governing this transaction was adopted on February 27, 2026.
Information limitations
Financial terms of the agreements with NewYork-Presbyterian, Columbia University and Weill Cornell Medicine were not publicly disclosed. It is also unclear what proportion of clinicians at these medical facilities will use the new AI tools in daily practice.
What shareholders should monitor
Shareholders should monitor the number of additional major medical systems adopting Doximity's AI toolset. Data on the scale and adoption pace of this technology is expected in future press releases and quarterly financial reports.
Original sources
- NewYork-Presbyterian, Columbia and Weill Cornell Medicine Bring Doximity's Clinical AI Into Epic
- 4 filing, November 9, 2026
- 144 filing, November 16, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Doximity
A notification in your browser or on your phone when we publish about Doximity. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
